NY A06605 | 2021-2022 | General Assembly

Status

Spectrum: Partisan Bill (Democrat 2-0)
Status: Introduced on March 19 2021 - 25% progression, died in committee
Action: 2022-01-05 - referred to ways and means
Pending: Assembly Ways and Means Committee
Text: Latest bill text (Introduced) [HTML]

Summary

Provides that the price of single source brand-name maintenance medication for which there is no National Average Drug Acquisition Cost pricing shall be the wholesale acquisition cost.

Tracking Information

Register now for our free OneVote public service or GAITS Pro trial account and you can begin tracking this and other legislation, all driven by the real-time data of the LegiScan API. Providing tools allowing you to research pending legislation, stay informed with email alerts, content feeds, and share dynamic reports. Use our new PolitiCorps to join with friends and collegaues to monitor & discuss bills through the process.

Monitor Legislation or view this same bill number from multiple sessions or take advantage of our national legislative search.

Title

Provides that the price of single source brand-name maintenance medication for which there is no National Average Drug Acquisition Cost pricing shall be the wholesale acquisition cost.

Sponsors


Roll Calls

2021-05-20 - Assembly - Assembly Health Committee: Favorable refer to committee Ways and Means (Y: 26 N: 0 NV: 0 Abs: 0) [PASS]

History

DateChamberAction
2022-01-05Assemblyreferred to ways and means
2021-05-20Assemblyreported referred to ways and means
2021-03-19Assemblyreferred to health

Same As/Similar To

S05401 (Same As) 2022-01-05 - REFERRED TO HEALTH

New York State Sources


Bill Comments

feedback